2023 has been a year of resilience and adaptation as the world continues to grapple with the challenges posed by...
The Dangerous Link Between Poor Vision and Falls in Seniors: Insights from Drugs.com MedNews As we age, our bodies undergo...
Milestone Pharmaceuticals, a biopharmaceutical company focused on developing innovative therapies for cardiovascular diseases, recently announced that its New Drug Application...
Cytokinetics, a biopharmaceutical company focused on the development of muscle activators and inhibitors, is rapidly approaching a crucial deadline in...
Smart packaging is revolutionizing the healthcare industry by providing valuable medication adherence insights rapidly. Medication non-adherence is a significant problem...
The Food and Drug Administration (FDA) has recently granted approval for LYFGENIA™ (lovotibeglogene autotemcel), a groundbreaking treatment for sickle cell...
FDA Approves Two Gene Therapies for Sickle Cell, Introducing New Paolo Macchiarini Series, and Exploring Fujifilm’s Niche The field of...
Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company, is intensifying its preparations for the commercial launch of resmetirom, a potential breakthrough treatment...
The Potential Impact of an Alzheimer’s Vaccine on Treatment Affordability Alzheimer’s disease is a progressive brain disorder that affects millions...
Sequana Medical, a Swiss medical device company, recently announced promising results from a non-randomized cohort in the US Phase 1/2a...
The increasing prevalence of home-based medical devices in ageing populations: A catalyst for healthcare empowerment As the global population continues...
In recent news, a Listeria outbreak has been linked to peaches and plums, resulting in one fatality and ten hospitalizations....
Title: Xeltis’ AXess Hemodialysis Vascular Conduit Trial Presents Promising 12-Month First-in-Human Data at VEITHsymposium 2023 Introduction Xeltis, a leading medical...
The Centers for Disease Control and Prevention (CDC) has announced plans to address the shortage of respiratory syncytial virus (RSV)...
The Food and Drug Administration (FDA) has recently granted approval for a new medication called DefenCath, which is a combination...
